Intuitive Surgical ISRG
$452.80 −$15.72 (-3.36%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $453.85 +0.23%
Open$457.00
Prev close$468.52
Day range$450.51 – $463.25
Volume2.15M
Market cap$156.96B
P/E (TTM)54.8
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$3.05B+21.7% YoY
Operating profit$1.04B+37.2% YoY
Net profit$524.40M-26.1% YoY
Diluted EPS$1.49-23.6% YoY
Free cash flow$1.11B+51.0% YoY
Operating cash flow$1.22B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin67.2%
Operating margin32.3%
Net margin25.5%
Return on equity18.0%
Return on assets15.3%
Return on invested capital16.3%
Current ratio3.33
Liabilities / assets16.7%
Cash & investments$4.04B
Net cash (debt)$4.04B
Free cash flow / sales31.1%
Where the revenue comes from
Quarter 2026/Q2
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $3.05B | $2.89B | $2.77B | $10.06B | $2.87B |
| Total Operating Revenue | $3.05B | $2.89B | $2.77B | $10.06B | $2.87B |
| Cost of Revenue | $964.40M | $931.90M | $940.30M | $3.42B | $961.90M |
| Gross Profit | $2.08B | $1.96B | $1.83B | $6.64B | $1.90B |
| Operating Expense | $1.04B | $988.50M | $975.20M | $3.70B | $1.04B |
| Selling and Admin Expenses | $633.40M | $617.90M | $613.30M | $2.39B | $687.10M |
| Research & Development | $408.30M | $370.60M | $361.90M | $1.31B | $352.90M |
| Operating Profit | $1.04B | $971.90M | $855.30M | $2.95B | $864.30M |
| Net Non-Operating Interest Income (Expense) | $75.80M | $82.70M | $85.10M | $365.90M | $91.30M |
| Non-Operating Interest Income | $75.80M | $82.70M | $85.10M | $365.90M | $91.30M |
| Other Income (Expense) | -$450.00M | – | – | – | – |
| Special Income (Charges) | -$450.00M | – | – | – | – |
| -Less:Other Special Charges | $450.00M | – | – | – | – |
| Pretax Profit | $668.40M | $1.05B | $940.40M | $3.31B | $955.60M |
| Tax | $144.00M | $231.40M | $114.40M | $434.80M | $156.10M |
| Net Profit | $524.40M | $823.20M | $826.00M | $2.88B | $799.50M |
| Profit from Continuing Operations | $524.40M | $823.20M | $826.00M | $2.88B | $799.50M |
| Minority Interests | $1.60M | $5.10M | $4.50M | $20.60M | $4.70M |
| Net Income to Parent Company | $522.80M | $818.10M | $821.50M | $2.86B | $794.80M |
| Net Income to Common Stockholders | $522.80M | $818.10M | $821.50M | $2.86B | $794.80M |
| Basic EPS | $1.50 | $2.31 | $2.31 | $8.00 | $2.24 |
| Diluted EPS | $1.49 | $2.29 | $2.28 | $7.87 | $2.21 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $19.35B | $20.88B | $20.11B | $20.46B | $20.46B |
| Total Current Assets | $8.43B | $9.54B | $8.81B | $9.78B | $9.78B |
| Cash and Cash Equivalents & Short-Term Investments | $4.04B | $5.22B | $4.52B | $5.93B | $5.93B |
| -Cash and Cash Equivalents | $2.98B | $2.76B | $2.01B | $3.37B | $3.37B |
| -Short Term Investments | $1.06B | $2.46B | $2.51B | $2.57B | $2.57B |
| Receivables | $1.83B | $1.77B | $1.71B | $1.63B | $1.63B |
| -Accounts Receivable | $1.47B | $1.43B | $1.39B | $1.53B | $1.53B |
| -Other Receivables | $381.70M | $370.20M | $352.70M | $100.90M | $100.90M |
| -Receivables Adjustments Allowances | -$28.50M | -$28.90M | -$32.70M | – | – |
| Prepaid Assets | $80.60M | $179.40M | $298.80M | – | – |
| Inventory | $2.13B | $2.03B | $1.95B | $1.84B | $1.84B |
| Other Current Assets | $352.00M | $343.70M | $337.20M | $376.40M | $376.40M |
| Total Non-Current Assets | $10.92B | $11.33B | $11.30B | $10.68B | $10.68B |
| Net PPE | $5.68B | $5.55B | $5.45B | $5.34B | $5.34B |
| Investments and Advances | $2.76B | $3.41B | $3.46B | $3.10B | $3.10B |
| -Available for Sale Securities | $2.76B | $3.41B | $3.46B | $3.10B | $3.10B |
| Goodwill and Other Intangible Assets | $754.50M | $778.60M | $780.70M | $381.40M | $381.40M |
| -Goodwill | $557.80M | $580.60M | $613.20M | $370.30M | $370.30M |
| -Other Intangible Assets | $196.70M | $198.00M | $167.50M | $11.10M | $11.10M |
| Non-Current Deferred Assets | $719.70M | $652.40M | $683.80M | $1.02B | $1.02B |
| Other Non-Current Assets | $1.01B | $942.10M | $927.20M | $837.60M | $837.60M |
| Total Liabilities | $3.23B | $2.58B | $2.51B | $2.52B | $2.52B |
| Total Current Liabilities | $2.53B | $1.92B | $1.91B | $2.01B | $2.01B |
| Payables | $498.30M | $442.50M | $488.60M | $380.50M | $380.50M |
| -Accounts Payable | $279.50M | $277.20M | $332.90M | $255.10M | $255.10M |
| -Total Tax Payable | $218.80M | $165.30M | $155.70M | $125.40M | $125.40M |
| Current Accrued Expenses | $987.60M | $505.30M | $492.20M | $470.60M | $470.60M |
| Current Deferred Liabilities | $541.20M | $549.40M | $559.50M | $506.70M | $506.70M |
| Total Non-Current Liabilities | $698.30M | $656.00M | $602.80M | $510.80M | $510.80M |
| Long Term Accounts Payable and Other Payables | $273.60M | $242.30M | $220.30M | $193.60M | $193.60M |
| Non-Current Deferred Liabilities | $128.20M | $112.60M | $104.00M | $91.40M | $91.40M |
| Other Non-Current Liabilities | $296.50M | $301.10M | $278.50M | $225.80M | $225.80M |
| Total Equity | $16.12B | $18.30B | $17.60B | $17.94B | $17.94B |
| Stockholders' Equity | $15.99B | $18.17B | $17.47B | $17.82B | $17.82B |
| Capital Stock | $300,000.00 | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 |
| -Common Stock | $300,000.00 | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $11.52B | $11.33B | $11.06B | $10.77B | $10.77B |
| Retained Earnings | $4.53B | $6.84B | $6.40B | $7.01B | $7.01B |
| Gains/Losses Not Affecting Retained Earnings | -$60.30M | $5.80M | $16.50M | $43.30M | $43.30M |
| Minority Interests | $131.60M | $129.30M | $122.70M | $117.70M | $117.70M |
| -Gross PPE | – | – | – | $7.62B | $7.62B |
| -Accumulated Depreciation | – | – | – | -$2.28B | -$2.28B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.22B | $1.06B | $911.90M | $3.03B | $892.50M |
| Net cash flow from continuing operations | $1.22B | $1.06B | $911.90M | $3.03B | $892.50M |
| Net Income from Continuing Operations | $524.40M | $823.20M | $826.00M | $2.88B | $799.50M |
| Gain/Loss from Continuing Operations | -$9.10M | -$8.80M | -$18.10M | -$58.20M | -$15.90M |
| Depreciation & Depletion & Amortization | $212.90M | $231.10M | $200.00M | $677.10M | $193.50M |
| Deferred Tax | -$54.40M | $31.00M | $339.30M | $19.10M | -$39.50M |
| Change in Working Capital | $337.70M | -$225.40M | -$644.80M | -$1.27B | -$248.40M |
| -Change in Receivables | -$53.40M | -$74.90M | $25.10M | -$301.70M | -$267.50M |
| -Change in Inventory | -$307.40M | -$248.00M | -$266.60M | -$1.06B | -$253.00M |
| -Change in Prepaid Assets | $11.30M | $90.30M | -$269.30M | -$187.10M | $61.80M |
| -Change in Payables and Accrued Expense | $234.40M | $2.50M | -$210.80M | $57.90M | -$39.10M |
| -Change in Other Current Liabilities | $595.00M | $6.10M | $30.70M | $34.10M | $28.90M |
| -Change In Other Working Capital | -$142.20M | -$1.40M | $46.10M | $187.90M | $220.50M |
| Net cash flow from investing | $1.90B | -$26.60M | -$914.50M | $665.80M | -$209.40M |
| Net Cash Flow from Continuing Investing Activities | $1.90B | -$26.60M | -$914.50M | $665.80M | -$209.40M |
| Net PPE Purchase and Sale | -$113.10M | -$112.60M | -$103.30M | -$539.80M | -$162.50M |
| Net Business Purchase and Sale | $9.60M | $0.00 | -$482.20M | -$13.90M | -$12.70M |
| Net Investment Purchase and Sale | $2.00B | $86.00M | -$329.00M | $1.22B | -$34.20M |
| Financing Cash Flow | -$2.89B | -$287.90M | -$1.35B | -$2.36B | -$137.50M |
| Net Cash Flow from Continuing Financing Activities | -$2.89B | -$287.90M | -$1.35B | -$2.36B | -$137.50M |
| Net Common Stock Issuance | -$2.98B | -$320.30M | -$1.12B | -$2.30B | -$201.00M |
| Proceeds from Stock Option Exercised | $96.40M | $65.60M | $121.80M | $350.30M | $76.60M |
| Net Other Financing Charges | -$14.30M | -$33.20M | -$352.30M | -$419.10M | -$13.10M |
| Ending Cash Balance | $3.02B | $2.81B | $2.05B | $3.41B | $3.41B |
| Net Change in Cash | $228.30M | $746.50M | -$1.36B | $1.33B | $545.60M |
| Beginning Cash Balance | $2.81B | $2.05B | $3.41B | $2.06B | $2.85B |
| Effect of Exchange Rate Changes | -$11.60M | $7.10M | $1.00M | $12.80M | $12.30M |
| Free Cash Flow | $1.11B | $948.40M | $808.60M | $2.49B | $730.00M |
No comments yet — be the first to weigh in on ISRG.
Sign in to join the discussion.